Skip to main content
Clinical Trials/NCT05766163
NCT05766163
Recruiting
Not Applicable

Comparative Evaluation of New Surgical Robotic Platforms for the Radical Prostatectomy Procedure

Azienda Ospedaliera Universitaria Integrata Verona1 site in 1 country150 target enrollmentMarch 14, 2023
ConditionsProstate Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Enrollment
150
Locations
1
Primary Endpoint
Number of participants with postoperative complications
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The object of this exploratory clinical trial is to evaluate post-operative complications in a population that underwent Robotic Assisted Radical Prostatectomy (RARP) made with multiple platforms:

  • DaVinci;
  • Hugo;
  • Versius.

The questions it aims to answer are:

  • Does the estimation of the post-operative complications suggest something?
  • Are differences (intra-operative, post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable?

Participants will be invited to fill out questionnaires and join one of these three groups:

  1. surgery with the daVinci platform;
  2. surgery with the Hugo platform;
  3. surgery with the Versius platform.
Registry
clinicaltrials.gov
Start Date
March 14, 2023
End Date
September 2024
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Alessandro Antonelli, MD, Prof

Director of Urology Unit

Azienda Ospedaliera Universitaria Integrata Verona

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 and \< 90 years;
  • Organ-localized prostate cancer with a surgical indication of radical prostatectomy;
  • Informed consent provided.

Exclusion Criteria

  • Age \< 18 and \> 90 years;
  • Contraindication to radical prostatectomy procedure;
  • Non-organ confined prostate cancer;
  • Refusal to participate.

Outcomes

Primary Outcomes

Number of participants with postoperative complications

Time Frame: Over the 4 days post surgery

Overall postoperative complications (% score \>0) are considered by Clavien-Dindo Classification 7 grades (I, II, IIIa, IIIb, IVa, IVb and V): the higher the grade, the higher the severity of the complication

Number of participants with moderate to major postoperative complications

Time Frame: Over the 4 days post surgery

Moderate to major complications (% score \>=2) are considered by Clavien-Dindo Classification 7 grades (I, II, IIIa, IIIb, IVa, IVb and V): the higher the grade, the higher the severity of the complication

Number of participants with major postoperative complications

Time Frame: Over the 4 days post surgery

Major complications (% score \>=3) are considered by Clavien-Dindo Classification 7 grades (I, II, IIIa, IIIb, IVa, IVb and V): the higher the grade, the higher the severity of the complication

Secondary Outcomes

  • Overall duration of the surgery(Intraoperative)
  • Number and type of intraoperative complications(Intraoperative)
  • Positive Surgical Margin(Up to 2 weeks postoperative (during histological analysis))
  • Lymph nodes resection(Intraoperative)
  • Urinary, sexual, and intestinal function assessment(Preoperative and follow-up (1, 3 and 6 months))
  • Procedure-related costs(From surgical procedure to the end of follow-up period (6 months))
  • Estimated Blood Loss(Intraoperative)
  • Postoperative pain(1-4 days postoperative)
  • Prostate Specific Antigen (PSA)(1 month follow-up)
  • Quality of Life Evaluation(Preoperative and follow-up at 1, 3 and 6 months)
  • Time taken for platform-related technical steps(From the room setting, through surgical procedure until postoperative room restoration for each of expected 150 surgeries (through study completion: an average of 1 year))
  • Anesthesia, Lymphadenectomy, Prostatectomy(Entrance of patient into operating room until completion of surgery)
  • Postoperative hospitalization(From the surgery day up to 10 days postoperative)
  • Possible malfunction of the platform(Intraoperative)

Study Sites (1)

Loading locations...

Similar Trials